Therapy News and Research

RSS

Children cured of acute lymphocytic leukemia after chemotherapy have a 5-20 times greater risk of developing secondary malignant neoplasm's

The alterations in the children's gene sequence remain embedded within their chromosomes and may pose elevated risk for development of second malignancies and other diseases later in life, cautioned Barry A. Finette, M.D., Ph.D., associate professor of pediatrics at the University of Vermont.

1 Jul 2004

Protein research may help develop new antibiotics

New findings about a protein that keeps cells alive by opening and closing pores within a cell's membrane may open the door to the development of new antibiotics.

30 Jun 2004

Women delay AIDS with vitamins B, C and E

Daily intake of multivitamins appears to delay the progress of the AIDS virus according to the results of a study of HIV infected women in Tanzania by Harvard researchers.

30 Jun 2004

$In Australia hip fracture numbers are expected to double over 29 years and quadruple in 56 years$

In Australia hip fracture numbers are expected to double over 29 years and quadruple in 56 years

Hip fracture rates are falling among older people but hospital admissions are rising despite the apparent success of prevention programs due to Australia’s aging population, says research in the Medical Journal of Australia.

30 Jun 2004

Alcon updates filing status of RETAANE® new drug application

Alcon, Inc. has announced that it has filed the second portion of its “rolling” New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for RETAANE® 15mg (anecortave acetate for depot suspension)

30 Jun 2004

Innovative research to apply microwave energy to the treatment of potentially deadly heart rhythm disorders

Innovative research by UTS engineers to apply microwave energy to the treatment of potentially deadly heart rhythm disorders has received an important boost from the National Health and Medical Research Council (NHMRC).

30 Jun 2004

Successes in frozen ovarian tissue technology may offer hope to women being treated for cancer

Doctors in Denmark have succeeded in producing a two-cell embryo after ovarian tissue was removed, frozen, and then thawed and replaced two years later.

29 Jun 2004

Chemotherapy agents as well as the newest biologic and targeted cancer therapy drugs, can harm a patient’s heart

Cancer treatments, including the most commonly used chemotherapy agents as well as the newest biologic and targeted therapy drugs, can harm a patient’s heart, sometimes fatally

29 Jun 2004

Immune modulation therapy, latest treatment for people with chronic heart failure

Here is the latest treatment for people with chronic heart failure: a nurse draws blood from the patient, runs that blood through a machine, superheating and “stressing” the blood, and then, injects it back into the patient.

29 Jun 2004

Relatively difficult for the AIDS virus to develop resistance to the drug, tenofovir, or the DAPY (diarylpyrimidine) family of compounds

HIV is a moving target, unpredictably changing direction to elude anti-AIDS drugs, but researchers at Rutgers are clearly on the track of solutions to combat HIV drug resistance.

29 Jun 2004

Launch of the Jeffrey Modell Diagnostic Center for Primary Immunodeficiencies

Mattel Children's Hospital at UCLA announced the launch of the Jeffrey Modell Diagnostic Center for Primary Immunodeficiencies at UCLA June 28.

29 Jun 2004

Men can live a long time after treatment for prostate cancer, and they deserve to have a good quality of life

As many prostate-cancer survivors have discovered, the lifesaving benefits of surgery, radiation and hormone therapy can come with a cost.

29 Jun 2004

94% of fertility patients never receive treatment

A review of global fertility care, completed for World Infertility Month (June), has revealed that 94% of the 90 million patients around the world with fertility problems never receive any kind of care for their condition.

29 Jun 2004

Treatment with Strattera makes children with ADHD fall asleep faster

Twice daily treatment with Strattera® (atomoxetine HCl), approved for the treatment of attention-deficit/hyperactivity disorder (ADHD), showed children with ADHD fell asleep faster compared to three-times daily treatment with methylphenidate

29 Jun 2004

Studies show new massage and physical therapy technique increased pregnancy rates in infertile women

The researchers reported that the Wurn Technique(R) (patent pending) is highly effective at increasing fertility in both natural conception and in vitro fertilization (IVF). The therapy uses neither drugs nor surgery.

29 Jun 2004

Iraqi doctors and senior nurses learn new techniques in head and neck cancer management

Thirty-two Iraqi Surgeons, Medical Oncologists and Senior Nurses travelled to the King Hussein Cancer Center in Amman, Jordan at the beginning of June to participate in a Seminar on Cancer Management.

29 Jun 2004

Continued commercial development of research into DNA repair

Recent developments have greatly improved the understanding of the mechanisms used by cells to identify and repair breaks in DNA, and the potential for drugs that target DNA repair in the treatment of a range of human diseases including cancer.

28 Jun 2004

Prince Charles has called for more research into the benefits of complementary therapies for cancer patients

His Royal Highness was speaking at a conference hosted by five major charities, including The Prince of Wales’s Foundation for Integrated Health of which he is President.

28 Jun 2004

Chemicals that inhibit the development of new blood vessels could prove to be a new way of treating endometriosis

Chemicals that inhibit the development of new blood vessels could prove to be a new way of treating endometriosis, according to research from The Netherlands and the USA presented today (Monday 28 June) at the 20th annual meeting of the European Society of Human Reproduction and Embryology.

28 Jun 2004

Hormone replacement therapy in women increases risk of dementia

These "surprising and significant findings" are reported in two studies from the Women's Health Initiative Memory Study, in which UC Medical Center participates, in today's issue of the Journal of the American Medical Association (JAMA).

28 Jun 2004

Therapy News and Research

Children cured of acute lymphocytic leukemia after chemotherapy have a 5-20 times greater risk of developing secondary malignant neoplasm's

Protein research may help develop new antibiotics

Women delay AIDS with vitamins B, C and E

In Australia hip fracture numbers are expected to double over 29 years and quadruple in 56 years

Alcon updates filing status of RETAANE® new drug application

Innovative research to apply microwave energy to the treatment of potentially deadly heart rhythm disorders

Successes in frozen ovarian tissue technology may offer hope to women being treated for cancer

Chemotherapy agents as well as the newest biologic and targeted cancer therapy drugs, can harm a patient’s heart

Immune modulation therapy, latest treatment for people with chronic heart failure

Relatively difficult for the AIDS virus to develop resistance to the drug, tenofovir, or the DAPY (diarylpyrimidine) family of compounds

Launch of the Jeffrey Modell Diagnostic Center for Primary Immunodeficiencies

Men can live a long time after treatment for prostate cancer, and they deserve to have a good quality of life

94% of fertility patients never receive treatment

Treatment with Strattera makes children with ADHD fall asleep faster

Studies show new massage and physical therapy technique increased pregnancy rates in infertile women

Iraqi doctors and senior nurses learn new techniques in head and neck cancer management

Continued commercial development of research into DNA repair

Prince Charles has called for more research into the benefits of complementary therapies for cancer patients

Chemicals that inhibit the development of new blood vessels could prove to be a new way of treating endometriosis

Hormone replacement therapy in women increases risk of dementia

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News